| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CNSP | Common Stock | Sale | -$13.6K | -5.5K | -2.19% | $2.47 | 246K | Dec 6, 2022 | See footnote | F1 |
| transaction | CNSP | Common Stock | Sale | -$13.5K | -5.5K | -2.24% | $2.46 | 240K | Dec 7, 2022 | See footnote | F1 |
| transaction | CNSP | Common Stock | Sale | -$13.2K | -5.5K | -2.29% | $2.40 | 235K | Dec 8, 2022 | See footnote | F1 |
| transaction | CNSP | Common Stock | Sale | -$6.8K | -2.8K | -1.19% | $2.43 | 232K | Dec 9, 2022 | See footnote | F1 |
| transaction | CNSP | Common Stock | Sale | -$6.45K | -5K | -2.16% | $1.29 | 227K | Mar 10, 2023 | See footnote | F1 |
| transaction | CNSP | Common Stock | Sale | -$6.5K | -5K | -2.2% | $1.30 | 222K | Mar 13, 2023 | See footnote | F1 |
| transaction | CNSP | Common Stock | Sale | -$6.75K | -5K | -2.25% | $1.35 | 217K | Mar 14, 2023 | See footnote | F1 |
| transaction | CNSP | Common Stock | Sale | -$6.1K | -5K | -2.31% | $1.22 | 212K | Mar 15, 2023 | See footnote | F1 |
| transaction | CNSP | Common Stock | Sale | -$6.2K | -5K | -2.36% | $1.24 | 207K | Mar 16, 2023 | See footnote | F1 |
| transaction | CNSP | Common Stock | Sale | -$5.65K | -5K | -2.42% | $1.13 | 202K | Mar 17, 2023 | See footnote | F1 |
| transaction | CNSP | Common Stock | Sale | -$5.4K | -5K | -2.48% | $1.08 | 197K | Mar 20, 2023 | See footnote | F1 |
| transaction | CNSP | Common Stock | Sale | -$5.5K | -5K | -2.54% | $1.10 | 192K | Mar 21, 2023 | See footnote | F1 |
| transaction | CNSP | Common Stock | Sale | -$5.4K | -5K | -2.61% | $1.08 | 187K | Mar 22, 2023 | See footnote | F1 |
| transaction | CNSP | Common Stock | Sale | -$10.8K | -10K | -5.35% | $1.08 | 177K | Mar 23, 2023 | See footnote | F1 |
| transaction | CNSP | Common Stock | Sale | -$5.4K | -5K | -2.83% | $1.08 | 172K | Mar 24, 2023 | See footnote | F1 |
| transaction | CNSP | Common Stock | Sale | -$5.45K | -5K | -2.91% | $1.09 | 167K | Mar 27, 2023 | See footnote | F1 |
| transaction | CNSP | Common Stock | Sale | -$10.4K | -10K | -5.99% | $1.04 | 157K | Mar 28, 2023 | See footnote | F1 |
Waldemar Priebe is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc. |